Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05303532
Title Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab (ROSY-D)
Recruitment Enrolling by invitation
Gender both
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications

hematologic cancer

Advanced Solid Tumor

Therapies

Durvalumab

Age Groups: senior | adult
Covered Countries ITA | FRA | DEU | CAN

Facility Status City State Zip Country Details
Research Site Newmarket Ontario L3Y 2P9 Canada Details
Research Site Besançon Cedex 25030 France Details
Research Site Bordeaux Cedex 33076 France Details
Research Site Brest 29200 France Details
Research Site Dijon cedex 21079 France Details
Research Site Lyon 69373 France Details
Research Site Marseille 13005 France Details
Research Site Montpellier 34090 France Details
Research Site Pierre Benite 69495 France Details
Research Site Rouen 76031 France Details
Research Site Saint Herblain 44805 France Details
Research Site Strasbourg 67091 France Details
Research Site Tours CEDEX 37044 France Details
Research Site Villejuif 94805 France Details
Research Site Guetersloh 33332 Germany Details
Research Site Muenster 48149 Germany Details
Research Site Arezzo 52100 Italy Details
Research Site Catania 95126 Italy Details
Research Site Meldola 47014 Italy Details
Research Site Milan 20141 Italy Details
Research Site Padova 35128 Italy Details
Research Site Pisa 56126 Italy Details
Research Site Roma 00128 Italy Details
Research Site Roma 00152 Italy Details
Research Site Busan 49241 Korea, Republic of Details
Research Site Seoul 6351 Korea, Republic of Details
Research Site Sheffield S10 2SJ United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field